An Automated Organoid Platform With Inter-Organoid Homogeneity And Inter-Patient Heterogeneity

Shengwei Jiang,Haoran Zhao,Weijie Zhang,Jiaqi Wang,Yuhong Liu,Yuanxiong Cao,Honghui Zheng,Zhiwei Hu,Shubin Wang,Yu Zhu,Wei Wang,Shuzhong Cui,Peter E Lobie,Laiqiang Huang,Shaohua Ma

DOI: https://doi.org/10.1016/j.xcrm.2020.100161

IF: 16.988

2020-01-01

Cell Reports Medicine

Abstract:Current organoid technologies require intensive manual manipulation and lack uniformity in organoid size and cell composition. We present here an automated organoid platform that generates uniform organoid precursors in high-throughput. This is achieved by templating from monodisperse Matrigel droplets and sequentially delivering them into wells using a synchronized microfluidic droplet printer. Each droplet encapsulates a certain number of cells (e.g., 1,500 cells), which statistically represent the heterogeneous cell population in a tumor section. The system produces >400-mu m organoids within 1 week with both inter-organoid homogeneity and inter-patient heterogeneity. This enables automated organoid printing to obtain one organoid per well. The organoids recapitulate 97% gene mutations in the parental tumor and reflect the patient-to-patient variation in drug response and sensitivity, from which we obtained more than 80% accuracy among the 21 patients investigated. This organoid platform is anticipated to fulfill the personalized medicine goal of 1-week high-throughput screening for cancer patients.